Palvella Therapeutics Stock Performance
| PVLA Stock | 103.98 1.32 1.25% |
On a scale of 0 to 100, Palvella Therapeutics holds a performance score of 8. The company holds a Beta of -0.26, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Palvella Therapeutics are expected to decrease at a much lower rate. During the bear market, Palvella Therapeutics is likely to outperform the market. Please check Palvella Therapeutics' treynor ratio, kurtosis, period momentum indicator, as well as the relationship between the downside variance and day median price , to make a quick decision on whether Palvella Therapeutics' historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Palvella Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain essential indicators, Palvella Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 7.3 M | |
| Free Cash Flow | -10.8 M |
Palvella Therapeutics Relative Risk vs. Return Landscape
If you would invest 7,767 in Palvella Therapeutics on October 18, 2025 and sell it today you would earn a total of 2,206 from holding Palvella Therapeutics or generate 28.4% return on investment over 90 days. Palvella Therapeutics is currently generating 0.531% in daily expected returns and assumes 5.1148% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Palvella, and 90% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Palvella Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Palvella Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Palvella Therapeutics, and traders can use it to determine the average amount a Palvella Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1038
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PVLA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Palvella Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Palvella Therapeutics by adding it to a well-diversified portfolio.
Palvella Therapeutics Fundamentals Growth
Palvella Stock prices reflect investors' perceptions of the future prospects and financial health of Palvella Therapeutics, and Palvella Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Palvella Stock performance.
| Return On Equity | -3.01 | ||||
| Return On Asset | -0.48 | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 11.84 M | ||||
| Price To Book | 31.82 X | ||||
| EBITDA | (13.12 M) | ||||
| Total Debt | 11.94 M | ||||
| Book Value Per Share | 3.49 X | ||||
| Cash Flow From Operations | (10.84 M) | ||||
| Earnings Per Share | (2.92) X | ||||
| Total Asset | 88.23 M | ||||
| Retained Earnings | (93.73 M) | ||||
About Palvella Therapeutics Performance
By analyzing Palvella Therapeutics' fundamental ratios, stakeholders can gain valuable insights into Palvella Therapeutics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Palvella Therapeutics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Palvella Therapeutics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Palvella Therapeutics performance evaluation
Checking the ongoing alerts about Palvella Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Palvella Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Palvella Therapeutics is way too risky over 90 days horizon | |
| Palvella Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (17.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Palvella Therapeutics generates negative cash flow from operations | |
| Over 76.0% of the company shares are owned by institutional investors |
- Analyzing Palvella Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Palvella Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Palvella Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Palvella Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Palvella Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Palvella Therapeutics' stock. These opinions can provide insight into Palvella Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Palvella Stock analysis
When running Palvella Therapeutics' price analysis, check to measure Palvella Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palvella Therapeutics is operating at the current time. Most of Palvella Therapeutics' value examination focuses on studying past and present price action to predict the probability of Palvella Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palvella Therapeutics' price. Additionally, you may evaluate how the addition of Palvella Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |